André Palma da Cunha Matta

Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial

Daniel S. Reich, Douglas L. Arnold, Patrick Vermersch et al. · The Lancet Neurology · 2021 · 177 citations · Full text

Neurological Disorder, Phase 2B, Clinical Trials +7

Effect of dimethyl fumarate on lymphocytes in RRMS

Devangi Mehta, Catherine Miller, Douglas L. Arnold et al. · Neurology · 2019 · 79 citations · Full text

Brazilian Consensus for the Treatment of Multiple Sclerosis: Brazilian Academy of Neurology and Brazilian Committee on Treatment and Research in Multiple Sclerosis

Vanessa Daccach Marques, Giordani Rodrigues dos Passos, María Fernanda Mendes et al. · Arquivos de Neuro-Psiquiatria · 2018 · 56 citations · Full text

Brazilian Guidelines for transcranial doppler in children and adolescents with sickle cell disease

Clarisse Lopes de Castro Lobo, Rodolfo Delfini Cançado, Ana Claúdia Celestino Bezerra Leite et al. · Revista Brasileira de Hematologia e Hemoterapia · 2010 · 26 citations · Full text

72-Week Safety and Tolerability of Dimethyl Fumarate in Japanese Patients with Relapsing-remitting Multiple Sclerosis: Analysis of the Randomised, Double Blind, Placebo-Controlled, Phase III APEX Study and its Open-Label Extension

Hirofumi Ochi, Masaaki Niino, Y. Onizuka et al. · Advances in Therapy · 2018 · 25 citations · Full text